Ładuje się......
Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
BACKGROUND: The lack of effective treatments for gliomas makes them a significant health problem and highlights the need for the development of novel and innovative treatment approaches. Immunotherapy is an appealing strategy because of the potential ability for immune cells to traffic to and destro...
Zapisane w:
Główni autorzy: | , , , , , , , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
BioMed Central
2011
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3229551/ https://ncbi.nlm.nih.gov/pubmed/22060015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-192 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|